Changes in activity of proline-specific peptidases in rat model for dementia of Alzheimer's type.

about

Changes in activity of proline-specific peptidases in rat model for dementia of Alzheimer's type.

Item

http://www.wikidata.org/entity/Q48313880

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Changes in activity of proline ...... dementia of Alzheimer's type.

@en

Changes in activity of proline ...... dementia of Alzheimer's type.

@nl

type

Item

label

Changes in activity of proline ...... dementia of Alzheimer's type.

@en

Changes in activity of proline ...... dementia of Alzheimer's type.

@nl

prefLabel

Changes in activity of proline ...... dementia of Alzheimer's type.

@en

Changes in activity of proline ...... dementia of Alzheimer's type.

@nl

P1476

Changes in activity of proline ...... r dementia of Alzheimer's type

@en

P2093

G A Nazarova

http://www.w3.org/2001/XMLSchema#string

N N Zolotov

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.

Alzheimer's disease genetics current status and future perspectives.

Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.

Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease.

Prolyl endopeptidase inhibitory activity of unsaturated fatty acids.

The expression of TRH, its receptors and degrading enzyme is differentially modulated in the rat limbic system during training in the Morris water maze.

A rapid radiochemical method for the determination of choline acetyltransferase.

Brain pharmacokinetics of two prolyl oligopeptidase inhibitors, JTP-4819 and KYP-2047, in the rat.

P2888

s10517-012-1796-3

P304

674-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10517-012-1796-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P50

K N Kolyasnikova

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23113255

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease